Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Mixed evidenceCoverage 5/5 core metricsOperating margin changed -2.5 percentage points from the prior annual period.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Operating margin compressed
Operating margin changed -2.5 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
- Free cash flow was negative
Latest reported free cash flow was -$636M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
- No current rule-based risk flags
3 filing-based checks were evaluable.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
- Revenue expanded
Latest reported annual revenue changed +11.7% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-09-06
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Medicare$1.57B100.0%no prior
Members sum to $1.57B against $45.4B consolidated (residual $43.9B) - eliminations or corporate lines the filer did not tag on this axis.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,058 US-listed filers · 868 in Financials| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $45.4B | 97thof 3,301 top third | 97thof 540 top third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | 11.8% | 65thof 3,137 middle third | 64thof 517 middle third |
Operating margin operating income ÷ revenue | 1.7% | 47thof 2,819 middle third | 37thof 233 middle third |
Net margin net income ÷ revenue | 1.0% | 45thof 3,263 middle third | 27thof 533 bottom third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | -1.4% | 32ndof 2,679 bottom third | 23rdof 306 bottom third |
Return on equity net income ÷ stockholders' equity (positive equity only) | 11.6% | 71stof 3,577 top third | 68thof 773 top third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 0.1% | 98thof 2,895 top third | 99thof 421 top third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 28 days | 74thof 2,398 top third | 63rdof 103 middle third |
Cash conversion operating cash flow ÷ net income (net income > 0) | -1.1× | 2ndof 1,954 bottom third | 3rdof 574 bottom third |
Cash-flow accrual ratio (net income − operating cash flow) ÷ average total assets · lower is ranked higher | 6.5% | 4thof 2,770 bottom third | 4thof 649 bottom third |
Balance-sheet accrual ratio change in net operating assets ÷ average net operating assets · lower is ranked higher | 26.2% | 23rdof 2,345 bottom third | 26thof 604 bottom third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 1 changed period| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Operating cash flow NetCashProvidedByUsedInOperatingActivities | quarter 2020-03-31 | $136M 10-Q 2020-05-01 | $143M 10-Q 2021-04-29 | +5.2% | first · latest |
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
debt, leases, revenue, segments, contingencies, taxes and more · the filer's own wordsCommitments and contingencies · 3,123 characters as filed
Commitments and Contingencies Legal Proceedings The healthcare industry is subject to numerous laws and regulations of federal, state, and local governments, as well as various contractual provisions, governing our operations. Compliance with these laws, regulations, and contractual provisions can be subject to government audit, review, and interpretation, as well as regulatory actions. Penalties associated with violations of these laws, regulations, and contractual provisions can include significant fines and penalties, temporary or permanent exclusion from participating in publicly funded programs, a limitation on our ability to market or sell products, the repayment of previously billed and collected revenues, and reputational damage. We are involved in legal actions in the ordinary course of business including, but not limited to, various employment claims, vendor disputes, and provider claims. Some of these legal actions seek monetary damages, including claims for punitive damages, which may not be covered by insurance. We review legal matters and update our estimates, or range of estimates, of reasonably possible and estimable losses and related disclosures, as necessary. We have accrued liabilities for legal matters for which we deem the loss to be both probable and reasonably estimable. These liability estimates could change as a result of further developments. The outcome of these legal actions are inherently uncertain. An adverse determination in one or more of thes …
CommitmentsAndContingenciesDisclosureTextBlock · excerpt; the full note is in the filing
Fair value · 2,340 characters as filed
Fair Value Measurements We consider the carrying amounts of current assets and current liabilities to approximate their fair values because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For our financial instruments measured at fair value on a recurring basis, we prioritize the inputs used in measuring fair value according to the three-tier fair value hierarchy. For a description of the methods and assumptions used to: a) estimate the fair value; and b) determine the classification according to the fair value hierarchy for each financial instrument, refer to our 2025 Annual Report on Form 10-K, Note 5, Fair Value Measurements. Our financial instruments measured at fair value on a recurring basis at June 30, 2026, were as follows: Observable Inputs Directly or Indirectly Observable Inputs Unobservable Inputs Total (Level 1) (Level 2) (Level 3) (In millions) Corporate debt securities $ 2,408 $ $ 2,408 $ Mortgage-backed securities 975 975 Asset-backed securities 354 354 Municipal securities 150 150 Other 43 43 Total assets $ 3,930 $ $ 3,930 $ Our financial instruments measured at fair value on a recurring basis at December 31, 2025, were as follows: Observable Inputs Directly or Indirectly Observable Inputs Unobservable Inputs Total (Level 1) (Level 2) (Level 3) (In millions) Corporate debt securities $ 2,465 $ $ 2,465 $ Mortgage-backed securities 953 953 Asset-backed securities 364 364 Municipal se …
FairValueDisclosuresTextBlock · excerpt; the full note is in the filing
Long-term debt · 3,163 characters as filed
Debt The following table summarizes our outstanding debt obligations: June 30, 2026 December 31, 2025 (In millions) Non-current long-term debt: 4.375% Notes due June 15, 2028 $ 800 $ 800 3.875% Notes due November 15, 2030 650 650 6.500% Notes due February 15, 2031 850 850 3.875% Notes due May 15, 2032 750 750 6.250% Notes due January 15, 2033 750 750 Deferred debt issuance costs (31) (34) Total $ 3,769 $ 3,766 Senior Notes Each of these notes are senior unsecured obligations of the Parent corporation, Molina Healthcare, Inc., and rank equally in right of payment with all existing and future senior debt, and senior to all existing and future subordinated debt of Molina Healthcare, Inc. The senior note indentures contain customary non-financial covenants and change of control provisions. As of June 30, 2026, we were in compliance with all non-financial covenants in the indentures governing the senior notes. The indentures governing the senior notes contain cross-default provisions that are triggered upon default by us or any of our subsidiaries on any indebtedness in excess of the amount specified in the applicable indenture. As discussed below, no amounts were outstanding under the Credit Agreement as of June 30, 2026, so there is no risk of a cross-default under the senior notes. Credit Agreement We are party to a Credit Agreement (the Credit Agreement) which includes a revolving credit facility (Credit Facility) of $1.25 billion, a $15 million swingline sub-facility, a $100 …
LongTermDebtTextBlock · excerpt; the full note is in the filing
New accounting pronouncements · 418 characters as filed
Recent Accounting Pronouncements Recent accounting pronouncements issued by the Financial Accounting Standards Board (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (SEC) did not have, nor does management expect such pronouncements to have, a significant impact on our present or future consolidated financial statements. …
NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing
Segment reporting · 4,400 characters as filed
Segments We currently have four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. Our reportable segments are consistent with how we currently manage the business and view the markets we serve. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which we offer managed healthcare services. The Other segment, which is insignificant to our consolidated results of operations, includes long-term services and supports consultative services in Wisconsin and the commercial portion of the business acquired in connection with the ConnectiCare transaction that closed effective February 1, 2025. The key metrics used to assess the performance of our segments are revenue, margin and medical care ratio (MCR). MCR represents the amount of medical care costs as a percentage of premium revenue. Therefore, the underlying margin, or the amount earned by the segments after medical or service costs are deducted from revenue, represents the most important measure of earnings reviewed by management, and is used by our chief executive officer, who is our chief operating decision maker, to review results, assess performance, and allocate resources. Such oversight and decision making includes, among others, pricing, approving capital expenditures, and identifying growth opportunities. We do not report total assets by segment since this is not a metric used to assess segment performance or allocate resource …
SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing
Significant accounting policies · 11,095 characters as filed
Significant Accounting Policies Cash and Cash Equivalents Cash and cash equivalents consist of cash and short-term, highly liquid investments that are both readily convertible into known amounts of cash and have a maturity of three months or less on the date of purchase. The following table provides a reconciliation of cash and cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in Restricted investments in the accompanying consolidated balance sheets. June 30, 2026 2025 (In millions) Cash and cash equivalents $ 4,985 $ 4,499 Restricted cash and cash equivalents 108 93 Total cash, cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows $ 5,093 $ 4,592 Receivables Receivables consist primarily of premium amounts due from government agencies, which are subject to potential retroactive adjustments, as well as pharmacy rebates and other receivables. Government receivables amounted to $2,442 million and $2,365 million at June 30, 2026 and December 31, 2025, respectively. We apply the current expected credit loss model to measure expected credit losses on our receivables based on available information about past events and reasonable and supportable forecasts. Because substan …
SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing
Source: SEC DERA Financial Statement and Notes data sets (txt.tsv), excerpts of the filer's own note text; the full note is in the linked filing. Excerpts are the first part of each note exactly as tagged in the filing; open the filing for the full text and the tables. Descriptive and educational, not advice.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.